)
Shukra Pharmaceuticals (524632) investor relations material
Shukra Pharmaceuticals Q1 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Un-audited standalone and consolidated financial results for the quarter ended June 30, 2026, were approved and reviewed by the Audit Committee and Board of Directors.
Both standalone and consolidated results were subject to a limited review by statutory auditors, with no material misstatements identified.
Financial highlights
Standalone revenue from operations for Q1 FY27 was ₹2,406.20 lakhs, up from ₹650.08 lakhs in Q1 FY26.
Standalone net profit for Q1 FY27 was ₹1,502.98 lakhs, compared to ₹102.96 lakhs in Q1 FY26.
Consolidated revenue from operations for Q1 FY27 was ₹2,406.20 lakhs, up from ₹650.08 lakhs in Q1 FY26.
Consolidated net profit for Q1 FY27 was ₹1,295.85 lakhs, compared to ₹102.96 lakhs in Q1 FY26.
Earnings per share (EPS) for Q1 FY27 stood at ₹0.34 (standalone) and ₹0.30 (consolidated), compared to ₹0.02 in Q1 FY26.
Outlook and guidance
No investor complaints were received or pending as of June 30, 2026.
The company continues to operate in two segments: Pharmaceuticals and MedTech, with the MedTech segment effective from October 1, 2025.
- Revenue and net profit surged year-over-year, with robust equity and no debt defaults.524632
Q4 25/26 - Q3 FY26 revenue and profit surged, with strong audit review and MD re-appointment.524632
Q3 25/26 - Q2 FY26 saw higher revenue, profit, and cash, with clean auditor review and no complaints.524632
Q2 25/26 - Q1 FY26 saw strong revenue and profit growth with clean auditor review.524632
Q1 25/26 - Q2 FY2024-25 revenue grew, but net profit and EPS fell; cash reserves increased.524632
Q2 24/25 - Q1 FY25 saw a significant drop in revenue and profit, but auditors raised no concerns.524632
Q1 24/25 - FY25 revenue and profit declined sharply, but financial position and compliance remain strong.524632
Q4 24/25 - Quarterly profit and revenue surged, with strengthened audit oversight.524632
Q3 24/25
Next Shukra Pharmaceuticals earnings date
Next Shukra Pharmaceuticals earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage